Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China · Delayed Price · Currency is CNY 72.43
+1.41 (1.99%)
At close: Sep 30, 2025
SHA:688192 Market Cap
SHA:688192 has a market cap or net worth of 33.28 billion as of October 3, 2025. Its market cap has increased by 113.25% in one year.
Market Cap
33.28B
Enterprise Value
32.21B
Revenue
511.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
72.43
Market Cap Chart
Since December 10, 2021, SHA:688192's market cap has increased from 16.44B to 33.28B, an increase of 102.40%. That is a compound annual growth rate of 20.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 33.28B | 93.04% |
| Dec 31, 2024 | 17.24B | -11.74% |
| Dec 29, 2023 | 19.53B | 21.84% |
| Dec 30, 2022 | 16.03B | 7.16% |
| Dec 31, 2021 | 14.96B | -9.01% |
| Dec 10, 2021 | 16.44B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 476.78B |
| WuXi AppTec | 328.32B |
| Shenzhen Mindray Bio-Medical Electronics | 297.14B |
| Sichuan Biokin Pharmaceutical | 150.50B |
| Shanghai United Imaging Healthcare | 124.40B |
| Zhangzhou Pientzehuang Pharmaceutical., | 118.73B |
| Aier Eye Hospital Group | 114.71B |
| Yunnan Baiyao Group Co.,Ltd | 101.26B |